RESUMEN
Europe is in the midst of a COVID-19 epidemic and a number of non-pharmaceutical public health and social measures have been implemented, in order to contain the transmission of severe acute respiratory syndrome coronavirus 2. These measures are fundamental elements of the public health approach to controlling transmission but have proven not to be sufficiently effective. Therefore, the European Centre for Disease Prevention and Control has conducted an assessment of research gaps that can help inform policy decisions regarding the COVID-19 response. We have identified research gaps in the area of non-pharmaceutical measures, physical distancing, contact tracing, transmission, communication, mental health, seasonality and environment/climate, surveillance and behavioural aspects of COVID-19. This prioritisation exercise is a step towards the global efforts of developing a coherent research road map in coping with the current epidemic but also developing preparedness measures for the next unexpected epidemic.
Asunto(s)
COVID-19/epidemiología , COVID-19/prevención & control , COVID-19/transmisión , Investigación , Prueba de COVID-19 , Comunicación , Trazado de Contacto , Monitoreo Epidemiológico , Humanos , Salud Mental , Distanciamiento Físico , SARS-CoV-2RESUMEN
Two months after the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the possibility of established and widespread community transmission in the European Union and European Economic Area (EU/EEA) is becoming more likely. We provide scenarios for use in preparedness for a possible widespread epidemic. The EU/EEA is moving towards the 'limited sustained transmission' phase. We propose actions to prepare for potential mitigation phases and coordinate efforts to protect the health of citizens.
Asunto(s)
Infecciones por Coronavirus/epidemiología , Planificación en Desastres , Epidemias , Planificación en Salud , Neumonía Viral/epidemiología , Anciano , Anciano de 80 o más Años , Betacoronavirus/patogenicidad , COVID-19 , Comorbilidad , Infecciones por Coronavirus/transmisión , Europa (Continente)/epidemiología , Unión Europea , Predicción , Humanos , Internacionalidad , Persona de Mediana Edad , Modelos Teóricos , Neumonía Viral/transmisión , Salud Pública , Factores de Riesgo , SARS-CoV-2 , IncertidumbreRESUMEN
Despite the recognized importance of health communication for disease prevention, a gap in knowledge was becoming apparent as regards the extent and nature of its use at the European level to support prevention and control of infectious diseases. To address this gap, the European Centre for Disease Prevention and Control (ECDC) commissioned in 2009 a consortium of universities to undertake a 3-year research project called "Translating Health Communications." The outcomes of this project comprise 2 major areas: (a) primary information gathering to provide insights into how health communication activities are currently being used for communicable disease prevention in the European Union and European Economic Area and (b) synthesis of knowledge on the evidence of use and application of health communication approaches. The overview of main findings of the project presented in this article highlights the many challenges that remain and the various areas of opportunity in order to raise the profile of health communication in the prevention of infectious diseases in the European context.
Asunto(s)
Control de Enfermedades Transmisibles/organización & administración , Comunicación en Salud/métodos , Europa (Continente) , Unión Europea , HumanosRESUMEN
Healthcare workers (HCWs) are often referred to as the most trusted source of vaccine-related information for their patients. However, the evidence suggests that a number of HCWs are vaccine-hesitant. This study consists of 65 semi-structured interviews with vaccine providers in Croatia, France, Greece, and Romania to investigate concerns HCWs might have about vaccination. The results revealed that vaccine hesitancy is present in all four countries among vaccine providers. The most important concern across all countries was the fear of vaccine side effects. New vaccines were singled out due to perceived lack of testing for vaccine safety and efficacy. Furthermore, while high trust in health authorities was expressed by HCWs, there was also strong mistrust of pharmaceutical companies due to perceived financial interests and lack of communication about side effects. The notion that it is a doctor's responsibility to respond to hesitant patients was reported in all countries. Concerns were also seen to be country- and context-specific. Strategies to improve confidence in vaccines should be adapted to the specific political, social, cultural and economic context of countries. Furthermore, while most interventions focus on education and improving information about vaccine safety, effectiveness, or the need for vaccines, concerns raised in this study identify other determinants of hesitancy that need addressing. The representativeness of the views of the interviewed HCWs must be interpreted with caution. This a qualitative study with a small sample size that included geographical areas where vaccination uptake was lower or where hesitancy was more prevalent and it reflects individual participants' beliefs and attitudes toward the topic. As HCWs have the potential of influencing patient vaccination uptake, it is crucial to improve their confidence in vaccination and engage them in activities targeting vaccine hesitancy among their patients.